Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Invested Capital (2019 - 2025)

Historic Invested Capital for Pharming (PHAR) over the last 4 years, with Q3 2022 value amounting to $143000.0.

  • Pharming's Invested Capital fell 6358.57% to $143000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $143000.0, marking a year-over-year decrease of 8361.18%. This contributed to the annual value of $165875.8 for FY2021, which is 117.07% down from last year.
  • Latest data reveals that Pharming reported Invested Capital of $143000.0 as of Q3 2022, which was down 6358.57% from $152000.0 recorded in Q2 2022.
  • In the past 5 years, Pharming's Invested Capital registered a high of $392702.7 during Q3 2021, and its lowest value of $143000.0 during Q3 2022.
  • In the last 4 years, Pharming's Invested Capital had a median value of $175266.6 in 2020 and averaged $208130.5.
  • As far as peak fluctuations go, Pharming's Invested Capital tumbled by 535.8% in 2021, and later plummeted by 6358.57% in 2022.
  • Over the past 4 years, Pharming's Invested Capital (Quarter) stood at $296645.9 in 2019, then crashed by 40.92% to $175266.6 in 2020, then fell by 5.36% to $165875.8 in 2021, then fell by 13.79% to $143000.0 in 2022.
  • Its Invested Capital was $143000.0 in Q3 2022, compared to $152000.0 in Q2 2022 and $162000.0 in Q1 2022.